230 related articles for article (PubMed ID: 21565333)
21. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
[TBL] [Abstract][Full Text] [Related]
22. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
23. RNA Interference of Human α-Synuclein in Mouse.
Kim YC; Miller A; Lins LC; Han SW; Keiser MS; Boudreau RL; Davidson BL; Narayanan NS
Front Neurol; 2017; 8():13. PubMed ID: 28197125
[TBL] [Abstract][Full Text] [Related]
24. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
25. Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease.
Johnston LC; Su X; Maguire-Zeiss K; Horovitz K; Ankoudinova I; Guschin D; Hadaczek P; Federoff HJ; Bankiewicz K; Forsayeth J
Mol Ther; 2008 Aug; 16(8):1392-9. PubMed ID: 18545225
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease.
Albert K; Voutilainen MH; Domanskyi A; Piepponen TP; Ahola S; Tuominen RK; Richie C; Harvey BK; Airavaara M
J Neurosci Res; 2019 Mar; 97(3):346-361. PubMed ID: 30548446
[TBL] [Abstract][Full Text] [Related]
27. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
Kirik D; Rosenblad C; Burger C; Lundberg C; Johansen TE; Muzyczka N; Mandel RJ; Björklund A
J Neurosci; 2002 Apr; 22(7):2780-91. PubMed ID: 11923443
[TBL] [Abstract][Full Text] [Related]
28. Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats.
McCoy MK; Ruhn KA; Martinez TN; McAlpine FE; Blesch A; Tansey MG
Mol Ther; 2008 Sep; 16(9):1572-9. PubMed ID: 18628756
[TBL] [Abstract][Full Text] [Related]
29. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
[TBL] [Abstract][Full Text] [Related]
30. Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.
Gombash SE; Lipton JW; Collier TJ; Madhavan L; Steece-Collier K; Cole-Strauss A; Terpstra BT; Spieles-Engemann AL; Daley BF; Wohlgenant SL; Thompson VB; Manfredsson FP; Mandel RJ; Sortwell CE
Mol Ther; 2012 Mar; 20(3):544-54. PubMed ID: 22008908
[TBL] [Abstract][Full Text] [Related]
31. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
Caudal D; Alvarsson A; Björklund A; Svenningsson P
Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
[TBL] [Abstract][Full Text] [Related]
32. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation.
Andersen MA; Christensen KV; Badolo L; Smith GP; Jeggo R; Jensen PH; Andersen KJ; Sotty F
Neurobiol Dis; 2018 Aug; 116():13-27. PubMed ID: 29680709
[TBL] [Abstract][Full Text] [Related]
33. Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
Neuroscience; 2012 Feb; 203():170-9. PubMed ID: 22198020
[TBL] [Abstract][Full Text] [Related]
34. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor PTEN regulates motor responses to striatal dopamine in normal and Parkinsonian animals.
Stavarache MA; Musatov S; McGill M; Vernov M; Kaplitt MG
Neurobiol Dis; 2015 Oct; 82():487-494. PubMed ID: 26232589
[TBL] [Abstract][Full Text] [Related]
36. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
[TBL] [Abstract][Full Text] [Related]
37. Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression.
Fischer DL; Manfredsson FP; Kemp CJ; Cole-Strauss A; Lipton JW; Duffy MF; Polinski NK; Steece-Collier K; Collier TJ; Gombash SE; Buhlinger DJ; Sortwell CE
Sci Rep; 2017 Nov; 7(1):16356. PubMed ID: 29180681
[TBL] [Abstract][Full Text] [Related]
38. Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease.
Ulusoy A; Decressac M; Kirik D; Björklund A
Prog Brain Res; 2010; 184():89-111. PubMed ID: 20887871
[TBL] [Abstract][Full Text] [Related]
39. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes.
Zhang W; Zhou M; Lu W; Gong J; Gao F; Li Y; Xu X; Lin Y; Zhang X; Ding L; Zhang Z; Li G; Chen X; Sun X; Zhu X; Xu P; Zhang Y
Theranostics; 2020; 10(7):3000-3021. PubMed ID: 32194851
[No Abstract] [Full Text] [Related]
40. Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein.
Chen YH; Wu KJ; Hsieh W; Harvey BK; Hoffer BJ; Wang Y; Yu SJ
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
